Obesity
- اقتصاد
Novo Nordisk Faces Defining Year in the Obesity Drug Market
Mike Doustdar, CEO of Novo Nordisk, speaks in the Oval Office during an event about weight loss drugs at the…
أكمل القراءة » - اقتصاد
2026 Is the Year of Obesity Pills From Novo Nordisk, Eli Lilly
The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its…
أكمل القراءة »
